JAGX
Jaguar Animal Health Inc
NASDAQ: JAGX · HEALTHCARE · BIOTECHNOLOGY
$6.96
+2993.33% today
Updated 2026-04-30
Market cap
$3.65M
P/E ratio
—
P/S ratio
0.32x
EPS (TTM)
$-22.97
Dividend yield
—
52W range
$0 – $13
Volume
0.6M
Jaguar Animal Health Inc (JAGX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-632.00%
ROE
-411.60%
ROA
-61.50%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2007 | $303297.00 | $-25.53M | 100.00% | -7,303.65% | -8,416.39% |
| 2014 | $0.00 | $-8.61M | — | — | — |
| 2015 | $258381.00 | $-16.29M | 52.22% | -4,816.67% | -6,305.24% |
| 2016 | $141523.00 | $-14.73M | 63.28% | -9,599.84% | -10,410.87% |
| 2017 | $4.36M | $-21.97M | 79.81% | -785.27% | -503.73% |
| 2018 | $4.42M | $-32.15M | 37.37% | -697.98% | -727.92% |
| 2019 | $5.78M | $-38.54M | 33.92% | -501.26% | -667.34% |
| 2020 | $9.38M | $-33.81M | 65.05% | -283.93% | -360.25% |
| 2021 | $4.33M | $-52.59M | 46.18% | -939.05% | -1,213.26% |
| 2022 | $11.96M | $-47.45M | 83.11% | -287.85% | -396.91% |
| 2023 | $9.76M | $-41.30M | 79.13% | -351.31% | -423.11% |
| 2024 | $11.69M | $-38.49M | 83.27% | -263.76% | -329.30% |
| 2025 | $11.51M | $-53.58M | 67.21% | -398.82% | -465.42% |